GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » FCF Yield %

FibroBiologics (FibroBiologics) FCF Yield % : -2.41 (As of May. 11, 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, FibroBiologics's Trailing 12-Month Free Cash Flow is $-6.90 Mil, and Market Cap is $303.96 Mil. Therefore, FibroBiologics's FCF Yield % for today is -2.41%.

The historical rank and industry rank for FibroBiologics's FCF Yield % or its related term are showing as below:

FBLG' s FCF Yield % Range Over the Past 10 Years
Min: -237.88   Med: 0   Max: 0
Current: -2.41

FBLG's FCF Yield % is ranked better than
78.28% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs FBLG: -2.41

FibroBiologics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

FibroBiologics FCF Yield % Historical Data

The historical data trend for FibroBiologics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics FCF Yield % Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of FibroBiologics's FCF Yield %

For the Biotechnology subindustry, FibroBiologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroBiologics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where FibroBiologics's FCF Yield % falls into.


FibroBiologics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

FibroBiologics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.896 / 0
=N/A%

FibroBiologics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

FibroBiologics FCF Yield % Related Terms

Thank you for viewing the detailed overview of FibroBiologics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (FibroBiologics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
SG0:Germany
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines

From GuruFocus

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

By PRNewswire • 02-12-2024

FibroBiologics Announces Three United States Patents for Fibroblast Technology

By PRNewswire • 02-12-2024